#CapVest

@newsen.bsky.social

6 months ago

Canson Capital Partners Leads CapVest's Acquisition of STADA Canson Capital Partners has announced its role as the lead financial advisor for CapVest Partners in its acquisition of STADA, marking a significant milestone in its investment journey.

Canson Capital Partners Leads CapVest's Acquisition of STADA #London #United_Kingdom #STADA #Canson_Capital #CapVest

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Canson Capital Partners Acts as Key Financial Advisor for CapVest in STADA Acquisition Canson Capital Partners has acted as the lead financial advisor to CapVest in the acquisition of STADA. This marks another significant collaboration in the healthcare sector.

Canson Capital Partners Acts as Key Financial Advisor for CapVest in STADA Acquisition #London #United_Kingdom #Canson_Capital #CapVest #STADA_Arzneimittel

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Canson Capital Partners Advises CapVest on STADA Acquisition and Co-Investment Canson Capital Partners has acted as Lead Financial Advisor for CapVest's acquisition of STADA Arzneimittel AG, marking a significant transaction in healthcare.

Canson Capital Partners Advises CapVest on STADA Acquisition and Co-Investment #London #United_Kingdom #Canson_Capital #CapVest #STADA_Arzneimittel

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Canson Capital Partners Leads Financial Advisory Role in CapVest's Acquisition of STADA Canson Capital Partners has successfully acted as the lead financial advisor for CapVest's acquisition of STADA, marking a significant milestone in private equity transactions.

Canson Capital Partners Leads Financial Advisory Role in CapVest's Acquisition of STADA #London #United_Kingdom #STADA #Canson_Capital #CapVest

0 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

6 months ago

CapVest strikes deal to buy majority of Stada from Bain, Cinven Investing.com -- Bain Capital and Cinven in a joint statement on Monday said they will sell a majority stake in German drugmaker Stada Arzneimittel AG to CapVest Partners LLP, with the deal expected to close in the first half of 2026 . Bain Capital and Cinven acquired Stada in 2017 and took it private. Under their ownership, the company expanded from a traditional generics business into a diversified healthcare platform with operations in consumer healthcare, generics and specialty pharmaceuticals. Stada reported sales of €4.06 billion in 2024 and adjusted EBITDA of €886 million, employing about 11,600 people worldwide. During the eight years of ownership, the firms supported more than 25 acquisitions, including Johnson & Johnson’s Nizoral brand, Czech supplement maker Walmark, and consumer health portfolios from GlaxoSmithKline and Sanofi. The acquisitions expanded Stada’s presence in Europe and other markets . Stada’s chief executive officer Peter Goldschmidt said the company grew internationally and increased innovation under Bain and Cinven. Dr. Michael Siefke, a partner at Bain Capital, said the firm worked to strengthen consumer healthcare, generics and specialty medicines during its investment. Supraj Rajagopalan, co-managing partner at Cinven, said the company invested in digitalization, operational improvements and governance structures. CapVest specializes in healthcare investments and will become the new majority owner. Bain Capital and Cinven will retain minority stakes in Stada after the transaction closes. Jefferies and Rothschild & Co are serving as lead merger-and-acquisition advisers. The terms of the transaction were not disclosed. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. Which stocks should you consider in your very next trade? The best opportunities often hide in plain sight—buried among thousands of stocks you'd never have time to research individually. That's why smart investors use our Stock Screener with 50+ predefined screens and 160+ customizable filters to surface hidden gems instantly. For example, the Piotroski's Picks method averages 23% annual returns by focusing on financial strength, and you can get it as a standalone screen. Momentum Masters catches stocks gaining serious traction, while Blue-Chip Bargains finds undervalued giants. With screens for dividends, growth, value, and more, you'll discover opportunities others miss. Our current favorite screen is Under $10/share, which is great for discovering stocks trading under $10 with recent price momentum showing some very impressive returns!

Click Subscribe #CapVest #Stada #BainCapital #Cinven #PrivateEquity

0 0 0 0

J.H. Rupprecht

@rupprecht.bsky.social

6 months ago

Stada: Finanzinvestor CapVest vor Übernahme des Generikaherstellers Zuletzt stand ein Börsengang im Herbst im Raum. Nun heißt es, dass Londoner Finanzinvestor CapVest den Arzneihersteller Stada kaufen will. Der Kaufpreis soll 10 Milliarden Euro betragen.

NEU Arzneimittelhersteller #Stada: Stand zuletzt ein Börsengang im Herbst im Raum, heißt es nun, dass Londoner Finanzinvestor #CapVest das deutsche Pharmaunternehmen kaufen will. Der Kaufpreis soll 10 Mrd. Euro betragen #Generika #Medizin #Deutschland #Pharma #Industrie #Produktion #Pharmaindustrie